Complementary DNAs encoding two forms of cocaine-and amphetamine-regulated transcript (CART) peptide precursors were identified from goldfish brain and named CART I and CART II. Each cDNA contains a signal peptide sequence, the putative CART-like peptide, and a carboxy-terminal extension peptide. Form I encodes a 117-amino acid pro-CART, whereas form II encodes a 120-amino acid pro-CART. Both forms resemble mammalian CART peptides. Each goldfish CART precursor is encoded by three exons interrupted by two introns within genomic DNA. RT-PCR, slot blot, and Northern blot analysis showed that the mRNAs for form I and II precursors have a widespread distribution. Form I and II are present in the brain, pituitary, eye, gonads, and kidney. Form I is also present in the gill. In the brain, form I is predominant in the olfactory bulb and hypothalamus, and form II is predominant in the optic tectum. Food deprivation for 96 h induced a decrease in form I mRNA levels in the telencephalonpreoptic region, hypothalamus, and olfactory bulb and in form II mRNA expression in the olfactory bulb. An increase in mRNA levels was observed 2 h following a meal in the olfactory bulbs and hypothalamus for form I whereas no postprandial changes in form II mRNA levels were observed. Intracerebroventricular injections of human CART alone induced a significant decrease in food intake. Injections of leptin reinforced the inhibition of feeding behavior and food intake seen in CART-treated fish. Central injection of leptin induced an increase in CART I mRNA in the optic tectum, hypothalamus, and olfactory bulbs but had no effect on CART II mRNA expression in the brain. These results suggest that CART peptides act as leptin-regulated satiety factors in goldfish and that they might have other physiological roles besides feeding, possibly in sensory information processing. (Endocrinology 142: 5076 -5088, 2001)
C OCAINE-AND AMPHETAMINE-regulated transcript (CART) peptides are novel neuropeptides that are thought to be involved in multiple physiological functions, including feeding, endocrine regulation, and mediation of the stress response (1) .
CART was initially isolated using PCR differential display as mRNA which levels increased in the rat striatum following acute administration of psychomotor stimulants such as cocaine and amphetamine (2) . The amino acid sequence deduced from CART mRNA corresponded to the unknown peptide isolated from ovine hypothalamus by Spiess et al. (3) . To date, cDNA encoding for CART has been cloned in rat (2) , mouse (4) , and human (5) . The mammalian pre-pro-CART peptide has a 27 amino acid signal peptide, followed by a pro-CART protein. CART mRNA is found in two alternatively spliced forms, which results in the production of two pro-CART peptides, the long form, with 102 amino acid residues, and the short form, with 89 amino acid residues. Rodents possess the two forms, whereas only the short form is present in humans. In rodents, the shorter variant is more abundant than the long form (2, 6) . Pro-CART has several potential cleavage sites (5) , which are indicative of further processing of CART proteins into smaller peptides. To date, at least six CART peptides have been identified in mammals (7) . The processing of CART peptides appears to be tissue specific (7, 8) .
In addition to the mammalian brain, CART peptides are also found throughout the nervous system and in the spinal cord, pituitary, gut, pancreas, and adrenals (6 -15) .
In mammals, CART peptides have a major role in the regulation of feeding. CART mRNA is expressed in hypothalamic areas implicated in the control of feeding behavior, such as the arcuate and paraventricular nucleus (2, 16 -18) . CART injections increase c-fos expression in the hypothalamus (19, 20) , and CART neurons establish synaptic connections with neurons expressing other hypothalamic appetiteregulating peptides (21, 22) . CART mRNA expression is lowered in fasting conditions (16, 23) . Central injections of CART fragments of various lengths have been shown to cause a dose-dependent feeding inhibition in rodents (8, 16, 24 -31) and to decrease NPY-induced feeding (24, 32) . CART , a naturally occurring fragment isolated from ovine hypothalamus (3), appears to be the most potent fragment. The numbers in the fragments derive from the predicted signal peptide cleavage site in the long form of CART (5) . CART peptides appear to be regulated by the adipocyte hormone leptin. CART mRNA expression is greatly reduced in obese ob/ob rats (16, 23, 32) and anorexic anx/anx mice (33) , both of which also have low circulating levels of leptin. Leptin treatment activates CART hypothalamic neurons (34) and increases CART mRNA expression in the hypothalamic arcuate nucleus (16, 35) .
In goldfish, several appetite-related neuropeptides have been isolated (36) . These include neuropeptide Y (37), corticotropin-releasing factor (38) , cholecystokinin (39) , and gastrin-releasing peptide (40) . We recently showed that two human CART fragments, CART 62-76 and CART 55-102, act as potent satiety factors when centrally injected in goldfish (41) , suggesting the presence and a physiological role of CART-like peptides in fish. Recent data also suggest the presence of CART peptide immunoreactivity in Atlantic salmon brain (42) . To date, little is known about the structure of CART peptides in nonmammalian vertebrates.
In this study we have determined the nucleotide sequence of cDNAs encoding two forms of CART-like peptides in goldfish. We used RT-PCR, Northern blot, and slot blot analyses to examine the distribution and quantify CART mRNA in several tissues. We also examined the effects of fasting on CART mRNA expression in brain and its variations following a meal. To examine whether CART effects on food intake are regulated by leptin, we assessed feeding behavior in fish submitted to intracerebroventricular coinjections of CART and leptin and evaluated the effects of leptin treatment on CART gene expression in brain.
Materials and Methods Animals
Male and female goldfish ranging from 35 to 75 g in weight were purchased from Mount Parnell Fisheries, Inc. (Mercersburg, PA). Fish were kept under a simulated photoperiod of 16-h light, 8-h dark in 65-liter tanks that received a constant flow of aerated water at 18 C. Fish were fed a 2% wet body weight (bw) ration once a day (0800 h), with commercially prepared trout pellets (Moore Clark, St. Andrews, New Brunswick, Canada). Fish were either mature (prespawning) or in gonadal recrudescence. Fish were anesthetized in 0.05% tricaine methanesulfonate (MS-222; Syndel Laboratories, Vancouver, British Columbia, Canada) before decapitation and dissection of the brain and other tissues. All experiments were carried out in accordance with the principles published in the Canadian Council on Animal Care's guide to the care and use of experimental animals.
Preparation of RNA
Total RNA from whole brain, eye, liver, gastrointestinal tract, kidney, gill, gonads, and muscle and various brain areas, including olfactory bulbs and tracts, telencephalon and the preoptic region, hypothalamus, optic tectum-thalamus, and posterior brain (cerebellum-medulla), were extracted from fresh tissues by a single-step acid guanidinium thiocyanate-phenol-chloroform extraction method using Trizol RNA isolation reagent (Life Technologies, Inc./BRL, Gaithersburg, MD). Final RNA concentrations were determined by optical density reading at 260 nm.
Cloning of cDNA by reverse transcription (RT) and rapid amplification of cDNA ends (RACE)
To isolate the 3Ј-end of cDNA, two partially degenerated primers, P1 (GCCGGNGAGCARTGYGCNGT) and P2 (GGGAAGYTNTGYGAYT-GYCC) were designed on the basis of the putative biological active (C-terminal) portion of CART peptides in the sequences of mammalian CART (primers shown in Fig. 1C ). Total RNA was reverse transcribed with dT-AP (GGCCACGCGTCGACTAGTAC(T) 17 ) using SuperScript II reverse transcriptase (Life Technologies, Inc.). The 3Ј-end of cDNA was amplified by two rounds of PCR, with adaptor primer (AP, GGC-CACGCGTCGACTAGTAC) and P1, and AP and P2, respectively, using a Robocycler 40 temperature cycler (Stratagene, La Jolla, CA). PCR products were separated by agarose gel electrophoresis, and the band of desired size was excised and purified using Geneclean II kit (Bio 101, La Jolla, CA). The desired PCR products were then subcloned using the pGEM-T vector system (Promega Corp., Madison, WI). Plasmid DNA containing the DNA insert was purified by an alkaline lysis method (43) . DNA sequence analyses were carried out on a PE Applied Biosystems automated sequencer (Perkin-Elmer Corp., Norwalk, CT) according to the manufacturer's protocol. Both strands of cloned DNA were sequenced in opposite directions using T7 and SP6 sequencing primers that flank the inserted DNA.
Following the identification of the 3Ј-end of the sequence, 5Ј-RACE was carried out to identify the 5Ј-end of the cDNA. New cDNA was synthesized by RT of total RNA with either P3 (AATTACACATCAA-GAGCAGC) or P6 (ATTGCACTTTAATGCAC). The 3Ј-end tailing of the cDNA with poly(A) was performed using terminal transferase (Life Technologies, Inc.). Tailing products were then amplified by two rounds of PCR using dT-adapter primer and P4 (CAAATTCCCCTGTTCTTCT-CACAG) or P7 (CAACTTTGCTTCAGTGTCTTC), and AP and P5 (CCCTGTTCTTCTCACAGCGCTTC) or P8 (GCTTCAGTGTCTTCA-GTCTCTTC), respectively. PCR products were then purified, cloned, and sequenced as described above.
Cloning of genomic DNA
Genomic DNA was isolated from gut tissue using Trizol reagent according to instructions of the manufacturer. DNA was then amplified by two rounds of PCR using P5 and P9 (GCAGAGGACGCTTGCT-GTGA) and P8 and P10 (GTTGCGCGCTAAATTCAGAACC). PCR products were then purified, cloned, and sequenced as described above.
Detection of mRNA expression in different tissues
RT-PCR assay and Southern blot analysis. Samples of total RNA were treated with RQ1 DNase (Promega Corp.) to ensure noncontamination with genomic DNA. Four micrograms total RNA were reverse transcribed into cDNA with dT-adapter primer using SuperScript II reverse transcriptase (Life Technologies, Inc.). A PCR amplification was carried out for 35 cycles with the primers Y1 (CCATGGAGAGCTCCAAACTC) and Y2 (TCTTGACCCTTTCCTGATGG) or F1 (TCTGATCTGCTTGTT-GACCG) and F2 (GTTTCGTCTGCAGCTTTTCC) (primers shown in Fig. 1C ). Twenty five microliters PCR reaction mixture were then fractionated in a 1.5% agarose gel, blotted onto Hybond-N membrane (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, UK) by capillary transfer and fixed by baking at 80 C for 2 h. The membranes were prehybridized at 65 C for 1 h in a hybridization solution containing 0.5 m NaHPO 4 (pH 7.2), 7% SDS, 1 mm EDTA (pH 8.0), and 1% BSA (fraction V, Sigma, St. Louis, MO). The membranes were then transferred into fresh hybridization solution to which labeled probe was added. The probes (P5/P9 and P8/P10) were synthesized by PCR using P5 and P9 (GCAGAGGACGCTTGCTGTGA) and P8 and P10 (GTTGCGCGCTAAATTCAGAACC) and 32 P labeled by a random primer method (T7 Quick Prime; Pharmacia, Uppsala, Sweden). Hybridization was carried out overnight at 65 C. The membranes were subsequently washed with a series of stringent washes (0.04 m NaHPO 4 , 1% SDS, 1 mm EDTA) and exposed to a phosphoimaging screen for 96 h. As a negative control, PCRs were performed in the absence of cDNA to examine the cross-contamination of samples.
As internal control of the RT step, PCR amplification was carried out for 35 cycles of 94 C for 1 min, 50 C for 1 min, and 73 C for 1 min with a pair of primers, A1 (CTACTGGTATTGTGATGGACTCCG) and A2 (TCCAGACAGAGTATTTGCGCTCAG), designed on the basis of ␤-actin partial cDNA sequence in goldfish (39) .
Northern blot
Fourty micrograms total RNA were denaturated in a formaldehyde/ formamide denaturing buffer (42% formamide, 8% 3-(N-morpholino)propanesulfonic acid, 15% formaldehyde) at 65-70 C for 15 min. RNA was then separated by electrophoresis on a formaldehyde-1.5% agarose gel. RNA was transferred to Hybond-N membrane by capillary transfer with 20ϫ saline sodium citrate. Membranes were fixed by baking at 80 C for 2 h and hybridized with either Y1/Y2 or F1/F2 probes. Probe labeling and hybridization were carried out as for Southern blots.
Slot blots
Ten micrograms total RNA samples from individual fish were denaturated in a denaturing solution (42% formamide, 1.6% 3-(Nmorpholino)propanesulfonic acid, 2 m formaldehyde) at 65 C for 15 min. Samples were then blotted onto Hybond-N nylon membrane (Amersham Pharmacia Biotech) by vacuum suction on a slot blot apparatus (Bio-Rad Laboratories, Inc.). The membranes were fixed by baking at 80 C for 2 h. Membranes were hybridized with either Y1/Y2 or F1/F2 probes. Probe labeling and hybridization were carried out as for Southern blots.
Intracerebroventricular (ICV) injections
Brain ICV injections were performed following procedures described by Peter and Gill (44) . Briefly, following deep anesthesia, a three-sided flap was cut in the roof of the skull using a dentist drill equipped with a circular saw. The flap was folded to the side, exposing the brain. Fish were then placed in a specially designed stereotaxic apparatus. The needle of a 5-l microsyringe was stereotaxically placed in the preoptic region of the brain third ventricle according to coordinates (ϩ 1.0 m, D 1.2) taken from the stereotaxic atlas of the goldfish brain (44) . Following injection of 2 l test solution, the needle was withdrawn and the space in the cranial cavity filled with teleost physiological saline (45) . The skull flap was put back in place and secured by surgical thread. Fish were then returned to their tanks and normally recovered from anesthesia within 2-5 min.
Fish were injected with different doses of human CART (55-102) (American Peptide Co., Inc., Sunnyvale, CA) and recombinant murine leptin (PeproTech, Inc., Rocky Hill, NJ) in teleost physiological saline. A stock solution of recombinant murine leptin was made in fish physiological solution acidified with 5 l 0.1 n HCl, and neutralized with 5 l 0.1 n NaOH. A stock solution of CART was made in saline. Stocks were aliquoted, stored at Ϫ20 C, and subsequently diluted in physiological saline.
Observational experiments
Fish were tested in random order in terms of treatment and days. Forty-eight hours before experimentation, two fish were moved into an observation tank and starved. For each experiment, two fish were injected and observed for feeding behavior and food consumption. An approximately 4% bw ration of pellets per fish was administered 15 min after injection. Experiments were carried out at the regular feeding time to which the fish had been adapted (0800 h). Behavioral observations and measurement of food consumption commenced upon entry of pellets into the tank and were made for 1 h. Observations were divided into 15-min periods. Feeding behavior and exploring behavior were monitored. Feeding behavior was assessed by counting the number of feeding acts. A "feeding act" was defined as an occasion when a fish approached a pellet. A feeding act was complete when the fish consumed the pellet or incomplete when the fish either engulfed a pellet and then spat it out or bumped it with a closed mouth. Food consumption was converted to milligrams of food consumed/wet bw per time feeding based on the mean pellet weight fed to fish.
The total number of acts (TA) was defined as the sum of the number of feeding acts and nonfeeding acts. The number of nonfeeding acts reflected locomotor/searching behavior and was assessed by counting the times fish mouthed, picked up, and spat gravel, or bumped any object in the tank (air stone, wall) or their tank mate.
To verify that the ICV procedure itself did not influence feeding, food intake was assessed for control fish submitted to either anesthesia alone or sham operations and compared with saline-treated animals.
Stressed animals were easily detected because they displayed characteristic behavioral signs, such as rapid opercular movements, lowering of the fins, or decreased locomotor activity. These fish did not feed and were not taken into consideration in the study.
Postprandial variations of CART mRNA expression
Five experimental groups, each containing six to eight fish, were acclimatized as described above. Fish were gonadal recrudescent (December to March). Preliminary studies showed no significant difference in CART mRNA expression between male and female groups (data not shown) in a given brain region and at a given sampling time. Consequently, both sexes were used in the experiments. On experimental day, a control (time zero) group was killed at the scheduled feeding time.
Brain tissue was sampled for total RNA extraction and determination of mRNA levels by slot blot analysis. Of the remaining four groups, two were fed with the normal ration and two remained unfed. One group of fed and one group of unfed fish were killed and sampled for brain tissue 2 and 6 h following food administration.
Effects of food deprivation on CART mRNA expression
Two experimental groups, each containing 8 -12 fish, were acclimatized as described above, before food deprivation. Control fish were fed a normal daily ration at 2% bw (0800 h). The experimental group was food deprived for 96 h. This fasting period was chosen as, in goldfish, 72-96 h fasting induces a significant increase in food intake (unpublished observations) and variations in the expression of appetite-related neuropeptides, such as NPY (47) . All fish were killed at the end of the food deprivation period, and brain tissues were collected for total RNA extraction and determination of mRNA levels by slot blot analysis.
Effects of leptin injections on CART-induced inhibition of feeding
Fish were submitted to ICV injections and observed for 1 h for assessment of food intake and feeding behavior. As controls, fish were submitted to ICV injections of either saline or vehicle (fish physiological solution acidified with 5 l 0.1 n HCl, and neutralized with 5 l 0.1 n NaOH). Because no significant difference in food intake was found between saline-and vehicle-treated fish, data from the two treatments were pooled into one group and used for comparison with all other treatment groups. Fish were ICV injected with saline/vehicle (n ϭ 15), leptin at 1 (n ϭ 7) or 5 ng/g (n ϭ 8), 5 ng/g CART (n ϭ 12), or coinjected with 5 ng/g CART and 1 ng/g leptin (n ϭ 7) or 5 ng/g CART and 1 ng/g leptin (n ϭ 8). The dose of 5 ng/g CART was chosen because it is within the range of optimal doses for inhibition of food intake (41) .
Effects of leptin injections on CART mRNA expression in the brain
CART gene expression was determined in four brain regions (telencephalon-preoptic region, hypothalamus, optic tectum, and olfactory bulbs) 2 and 6 h after ICV injection of saline and 6 h after ICV injection of 10 ng/g leptin. Fish were ICV injected, returned to their tank, and allowed to recover for 5-10 min. Fish were then given food pellets and observed for 1 h to verify that the fish behaved according to the treatment. Fish were then killed 2 or 6 h following food administration and sampled for brain tissues. A control group was injected with saline and killed and sampled for brain tissue 2-3 min after feeding. Total RNA was prepared and subjected to slot blot analysis.
Data analysis and statistics
Analysis of the sequences was performed using SignalP v1.1 software from the Center for Biological Sequence Analysis Web site (http:// www.cbs.dtu.dk/). Sequence comparisons were performed using MAP and ClustalW v1.8 from the Baylor College of Medicine Search Launcher Web site (http://searchlauncher.bcm.tmc.edu/).
In gene expression studies, the hybridization signals were scanned using PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) and quantified using ImageQuant software (Molecular Dynamics, Inc.). The mRNA levels for each CART form were expressed as a ratio of CART mRNA to ␤-actin mRNA levels (internal control) and normalized as a percentage of the mRNA levels from the control (time 0) group.
To compare variations of feeding parameters and postprandial and postleptin treatment variations of CART mRNA levels for a given brain area, statistical analyses were conducted using ANOVA followed by a pairwise Student-Newman-Keuls multiple comparison test. A t test was used to compare CART mRNA levels in fed and fasted fish in a given brain area. Significance was considered at P Ͻ 0.05. Data are expressed as mean Ϯ sem.
Results

Structure of the goldfish pre-pro-CART cDNA and genomic DNA
Analysis of the 3Ј-RACE products by agarose gel electrophoresis resulted in a major band of approximately 300 bp. After isolation and subcloning of these products, the nucleotide sequence of two 3Ј-ends of CART cDNAs was identified by sequence analysis of several clones. These fragments contained open reading frames for the C-terminal portion of CART precursors and were called form I and II. A 5Ј-RACE was performed using two sets of primers designed for each form (P3, P4, and P5 for form I and P6, P7, and P8 for form II). Analysis of the 5Ј-RACE products by agarose gel electrophoresis resulted in bands of approximately 600 bp. Sequence analysis showed that these were part of the 5Ј portions of the CART cDNAs. The nucleotide sequences of the overlapping portions were identical between the partial cDNA obtained by 3Ј-RACE and 5Ј-RACE. PCR amplification and sequence analysis for 3Ј-RACE and 5Ј-RACE were repeated to confirm that the sequences did not include errors caused by misincorporation. To verify the integrity of the sequence, brain cDNA was also amplified with different sets of primers (P5/P9 and P8/P10) located in the noncoding 5Ј and 3Ј regions of the cDNAs.
The CART form I precursor cDNA consists of 578 bp, comprising a 5Ј-untranslated region (47 bp) , an open reading frame (351 bp), a stop codon (TGA), and a 3Ј-untranslated region (177 bp), including two possible polyadenylation signals (AATAAA and ATTAAA) and a poly(A) tail (Fig. 1A) . The CART form II precursor cDNA consists of 654 bp, comprising a 5Ј-untranslated region (55 bp) , an open reading frame (360 bp), a stop codon (TGA), and a 3Ј-untranslated region (239 bp), including two possible polyadenylation signals (ATTAAA and AATAAA) and a poly(A) tail (Fig. 1B) .
The deduced amino acid sequence shows that goldfish CART form I and form II are part of a 117 and a 120 amino acids precursor, respectively. Potential signal peptide cleavage sites occur in the precursor after amino acid residue 25 (M) in form I and (A) in form II (Fig. 1) .
Both goldfish CART precursors also contain several potential enzyme cleavage recognition sites. These include two dibasic sites (Lys-Arg and Lys-Lys) at positions 71-72/78 -79 and 68 -69/75-76 for CART I and CART II, respectively.
To confirm the CART cDNA sequences, PCR of genomic DNA was performed to obtain partial gene sequences for CART. Comparison of goldfish cDNA and genomic DNA confirmed the sequence obtained by RACE and showed that CART mRNA is encoded by three exons. Two introns are located within the coding region at positions 54 (102 bp between nucleotides encoding L and L) and 82 (132 bp between nucleotides encoding T and C) for form I and 57 (174 bp between nucleotides encoding L and L) and 84 (304 bp between nucleotides encoding M and C) for form F (data not shown, GenBank accession numbers AY033816 and AY033817).
Tissue distribution of CART mRNA
Northern blot. Northern blot analysis revealed the presence of single bands of approximately 700 and 800 bp for CART I and CART II mRNAs, respectively (Fig. 2) . Bands were seen in total RNA from the olfactory bulb, hypothalamus, telencephalon-preoptic region, and optic tectum for form I, and hypothalamus, optic tectum, and telencephalon-preoptic region for form II. No signal was generated in the gut and ovary for either CART forms.
RT-PCR
RT-PCR of RNA with specific primers within the coding region of the goldfish CART form I and II cDNAs resulted in bands of expected size of 280 and 170 bp, respectively (Fig. 3 ) that were detected in Southern blot analysis. CART I mRNA was detected in the brain, eye, gill, kidney, ovary, and testis but not in the muscle, liver, and gut (Fig. 3) . CART II mRNA was detected in the brain, eye, kidney, testis, and ovary. Both CART I and II mRNAs were detected in all brain regions and in the pituitary (Fig. 3) . No products were detected from the negative control. PCR amplification of the cDNA samples using a specific primer set of goldfish ␤-actin (A1 and A2) was used as internal control of the RT step and revealed a band of 600 bp. The ␤-actin mRNA was detected in all tissues and brain samples examined, verifying the quality of the mRNA and DNA samples.
Quantification of CART mRNA by slot blot
To verify the specificity of the probes Y1/Y2 and F1/F2, tissues were submitted to RT-PCR with either primer sets P5/P9 or P8/P10, followed by Southern blot with probes F1/F2 and Y1/Y2, respectively. No cross-hybridization was seen for the two probes in Southern blot analysis (data not shown).
FIG. 2. Northern blot analysis of pre-pro-CART mRNA expression in different tissues of goldfish (n ϭ 2-4 fish).
Using slot blot with specific probes for each CART mRNA, both CART forms were detected in the brain and ovary but not in the GI tract (Fig. 4) . Within the brain, both forms I and II were detected in the optic tectum, telencephalon-preoptic region, hypothalamus, and olfactory bulbs but not in the posterior brain and pituitary (Fig. 4, A and B) . The olfactory bulbs exhibited the highest level of CART I mRNA, approximately 5-fold higher than that in the hypothalamus (Fig.  4A) . Form II was predominant in the optic tectum (Fig. 4B) .
In subsequent CART gene expression experiments, CART mRNA levels were quantified by slot blot analysis in the telencephalon-preoptic region, hypothalamus, optic tectumthalamus, and olfactory bulbs.
Postprandial CART mRNA expression
As revealed by slot blot analysis, CART I mRNA expression showed no postprandial variation in either the optic tectum or the telencephalon-preoptic region. CART I mRNA expression in these regions in both fed and unfed fish was identical to that of control (time zero) fish at 2 and 6 h after the scheduled feeding time (Fig. 5A ). In the hypothalamus and olfactory bulbs, CART I mRNA levels of fed fish were significantly higher than that of control fish and unfed fish 2 h following food administration. At 6 h, CART I hypothalamic levels in unfed fish were lower than that of control 0 h fish but similar to that of fed 6 h fish. In the olfactory bulbs, CART I mRNA levels in 6 h unfed fish were significantly lower than that of both 0 h control and 6 h fed fish.
There were no significant variations in CART II mRNA expression in either fed or unfed fish in optic tectum, telencephalon-preoptic region, hypothalamus, or olfactory bulbs at 0, 2, or 6 h following food administration (Fig. 5B) .
Effect of food restriction on CART mRNA expression
As revealed by slot blot analysis, food restriction for 4 d induced a decrease in expression of CART I mRNA in the telencephalon-preoptic region, hypothalamus, and olfactory bulbs but not in the optic tectum (Fig. 6) . Under the same conditions, CART II mRNA expression was decreased in the olfactory bulbs but not in the telencephalon, hypothalamus, and optic tectum.
Effects of ICV injection of murine leptin on CART-induced inhibition of feeding
At 1 and 5 ng/g, leptin had no significant effects on the cumulative number of pellets consumed at 60 min following presentation of food, compared with the saline group (Fig.  7A) . Doses of 5 ng/g CART caused a significant decrease in food intake after 60 min. The cumulative food intake in fish cotreated with 1 ng/g leptin and 5 ng/g CART was similar to that of fish treated with 5 ng/g CART. The cumulative food intake in fish cotreated with 5 ng/g leptin and 5 ng/g CART was lower than that of fish treated with 5 ng/g CART. Both groups of leptin/CART-treated fish had levels of feeding lower than that of the saline group.
The number of feeding acts in fish treated with CART, leptin, or CART/leptin was similar to that of control fish (Fig.  7B) . The number of TAs in leptin-treated fish was similar to that in control fish. Fish treated with 5 ng/g CART displayed more TAs than control fish. In fish cotreated with 5 ng/g CART and 1 ng/g leptin, the number of TAs was similar to both CART-and saline-treated fish. Fish cotreated with 5 ng/g CART and 5 ng/g leptin had a number of TAs similar to that of saline-treated fish.
Effects of leptin ICV on CART gene expression
Slot blot analysis revealed that, in the optic tectum, there were no significant differences in CART I (Fig. 8A) or CART II (Fig. 8B ) mRNA levels in saline-treated fish, at either 2 or 6 h after injection, compared with 0 h fish. At 6 h, leptintreated fish had CART I mRNA levels that were similar to 0 h fish but higher than 6 h saline-treated fish. At 6 h, leptintreated fish had CART II mRNA levels that were similar to both 0 and 6 h saline-treated fish.
In the telencephalon-preoptic region (Fig. 8, A and B) , there were no significant differences in either CART I or II mRNA levels in any group at 0, 2, or 6 h.
In the hypothalamus (Fig. 8A) , at 2 h after feeding, CART I mRNA levels were increased in saline-treated fish, compared with 0 h fish. At 6 h, CART I mRNA levels in salinetreated fish were similar to that of 0 h fish. At 6 h, leptintreated fish had CART I mRNA levels similar to that of the leptin-injected fish at 2 h and significantly higher than that of 0 and 6 h saline-treated fish. There were no significant differences in CART II hypothalamic mRNA levels in any group at 0, 2, or 6 h.
In the olfactory bulbs, at 2 h after feeding, levels of CART I mRNA were higher than that of 0 h fish, whereas levels of CART II mRNA were similar to that of 0 h fish (Fig. 8, A and  B) . At 6 h, levels of both CART I and II mRNA in salinetreated fish were similar to that of 0 h fish. At 6 h, leptintreated fish displayed levels of both CART I and II mRNAs that were similar to levels in 0 and 6 h saline-treated fish.
Discussion
Molecular cloning and structure of CART cDNA
In the present study, two distinct CART cDNA/genomic DNAs were identified in the goldfish. The two genes encode two forms of goldfish CART designated as CART I and CART II. The structure of the goldfish CART genes resemble that of mammalian CART and that of a cDNA encoding a CART-like peptide in zebrafish recently submitted to the GenBank database (46) . The coding sequence of goldfish CART gene is interrupted by two introns, and the full-length goldfish CART cDNA is approximately 600 -700 bp (700 -900 bp for mammalian CART), excluding the poly-A tail. The cDNAs encoding the two goldfish CART forms are 63% homologous. Nucleotide sequence comparison of the goldfish CART cDNAs to full-length mammalian CART cDNA reveals an identity of about 40%, with a 50% degree of homology within the coding region. As in mammalian CART transcripts, several putative poly (A)-addition sites are present in the 3Ј untranslated region of goldfish CART forms. In rodents, but not in humans, the presence of alternate polyadenylation sites results in a RNA doublet as revealed by Northern blot analysis (2, 5) . In spite of the presence of two possible polyadenylation sites in goldfish CART, only a single band is visible in Northern blot gels with both CART I and II. This suggests that, as in humans (5), only one transcript predominates for each CART I and CART II in vivo.
In rodents, CART mRNA is found in two alternatively spliced forms, resulting in the production of two proteins, the long and short forms. The long form, which is present in rodents but not in humans, originates from the translation of the last 29 nucleotides located at the end of the first exon (2). The short variant is more frequent than the long form (2, 4, 6). As in humans, goldfish do not appear to have splice variant forms.
Goldfish CART precursors are about 120 amino acids (aa), consisting of a short signal peptide (25 aa) and the mature peptide of approximately 100 aa. They present a high homology with their mammalian counterparts. The two goldfish pro-CART forms present 70% similarity, whereas the two mature forms are 76% homologous. Comparison of amino acid sequences with known sequences of other species show that for both pro-CART and mature CART, there is a 40 -50% homology between both goldfish and mammalian forms (Fig. 9) . In the C-terminal portions of the peptide sequences (last 46 aa), there is an 85% homology between the two goldfish forms and 70 -80% similarity between goldfish and mammalian CART. Variability occurs in the N-terminal portion of the peptide rather than its C-terminal end region, which is not surprising, because the C-terminal region is thought to be the biologically active segment of the CART. Because the portion (55-102) is highly homologous to mammalian CART (55-102), it is not surprising that central injection of human CART (55-102) in goldfish has pronounced effects on feeding (41) . Cysteine residues located in the same position in mammalian and goldfish CART peptides suggest the presence of disulfide bonds and an identical tertiary structure of the protein in the two species. This would account for the conservation of physiological activity of the human form in goldfish.
As in mammals, the goldfish CART amino acid sequence contains several potential dibasic cleavage sites, suggesting that in goldfish, CART peptides are similarly posttranscrip- (1) is absent in goldfish forms because Pro is substituted by a Thr. This suggests that the processing of CART might be species specific. It is noteworthy that, in spite of the evidence of cleavage given by goldfish cDNA, Western blot analysis in salmon brain detected only one immunoreactive peptide form with a molecular weight of 8 kDa (42) .
The genomic organization of the goldfish is tetraploid so that multiple forms of CART are not surprising. The two CART forms isolated in this study appear too different to originate from the same gene. In addition to these two forms, the presence of other forms of CART peptide variants in goldfish is not to be ruled out.
Distribution of CART mRNA in goldfish brain and peripheral tissues
We found CART mRNA throughout the goldfish brain and in the pituitary. The mRNAs of the two goldfish CART forms show a different distribution within the brain. Form I mRNA is most abundant in the olfactory bulb and hypothalamus, whereas form II mRNA shows highest levels in the optic tectum-thalamus. In the posterior brain and pituitary, mRNAs of both forms were detected by RT-PCR but not by FIG. 5 . Variations of CART I (A) and CART II (B) mRNA expression in optic tectum (OT), telencephalon-preoptic region (T), hypothalamus (H), and olfactory bulbs (OB) at 0, 2, and 6 h following the scheduled feeding time. Total RNA was prepared and subjected to slot blot analysis. CART mRNA levels were expressed as a ratio between CART mRNA and ␤-actin mRNA levels (internal control) and normalized as a percentage of CART mRNA in the control group (time zero). Data are mean Ϯ SEM (OT, T, H: n ϭ 6 -8 fish/group; OB: n ϭ 3 pools/group, 2-3 fish/pool). Bars with dissimilar superscripts indicate groups that differ significantly.
Northern blot or slot blot, suggesting a low expression in these regions. The distribution of form I is similar to that found in mammals, in which CART peptides and mRNA are present throughout the brain, including various regions of the hypothalamus, forebrain, midbrain, cortex, and cerebellum (2, 6, 11, 18, 48) . CART mRNA and peptides have also been shown in rat pituitary (6, 11, 12) . In salmon, CARTimmunoreactive material has been reported in the preoptic nucleus and laminar nucleus (42) . The presence of CART mRNA in goldfish hypothalamus and pituitary suggests a role of these peptides in endocrine regulation of fish. The presence of CART mRNA in the hypothalamus also concurs with the role of CART in regulating feeding in goldfish (41) . Notably, the highest levels of CART I mRNA were found in the olfactory bulbs of goldfish. High mRNA expression in goldfish olfactory bulbs have previously been shown for other satiety peptides, such as cholecystokinin (39, 49) , corticotropin-releasing factor (38) , and tachykinins (50) . This might be explained by the fact that, in goldfish, the olfactory bulbs play an important role in the regulation of feeding because the hypothalamus is connected to the olfactory system and olfactory tract lesions affect feeding behavior (51) . In mammals, CART immunoreactivity is found in the olfactory bulbs, retinal ganglion cells, and spinal cord, suggesting that CART peptides are involved in peripheral sensory information processing (6) .
The different expression pattern of CART II mRNA suggests that this peptide has a distinct role from that of CART I. CART II is expressed mainly in the brain, and it is present only at low levels in peripheral tissues. Within the brain, it is predominant in the optic tectum-thalamus. High levels of CART have also been demonstrated in human thalamus and other sensory-related brain regions (48) . A putative role of CART peptides in the transmission/reception of olfactory and visual information in the brain may account for the disturbances in motor activity, and the seizures and anxietylike behavior induced by central injection of CART peptides (26, 29, 31, 41, 52, 53) .
RT-PCR analysis did not reveal the presence of detectable CART mRNA in goldfish liver and muscle, which is in agreement with studies in mammals (2) . Messenger RNA encoding the CART precursor was not detected in the gastrointestinal tract of the goldfish. This is also consistent with what is known in mammals: even though stomach and intestine contain CART immunoreactivity (6, 11, 13, 14) , CART mRNA CART mRNA levels were expressed as a ratio between CART mRNA and ␤-actin mRNA levels (internal control) and normalized as a percentage of the control (fed) group. Data are mean Ϯ SEM (OT, T, H: n ϭ 8 -12 fish/group; OB: n ϭ 3 pools/group, 2-3 fish/pool). Stars indicate groups that differ significantly (t test).
FIG. 7. Effects of ICV injection of recombinant murine leptin on
CART-induced inhibition of food intake (A) and feeding and associated behaviors (B) in goldfish. Fish were injected with saline/vehicle (n ϭ 15), leptin at 1 (n ϭ 7) or 5 ng/g (n ϭ 8), 5 ng/g CART (n ϭ 12) or coinjected with 5 ng/g CART and 1 ng/g leptin (n ϭ 7) or 5 ng/g CART and 1 ng/g leptin (n ϭ 8). Fish received food 15 min after ICV injection and were observed for 1 h. In (A), the data are represented as the cumulative food intake of the injected fish 60 min after presentation of food. B, Total number of feeding acts (FA) includes pellets eaten, pellets engulfed and then spat out, and pellets bumped with a closed mouth. TAs include feeding acts as well as nonfeeding acts (gravel spitting, bumping on walls, any inanimate object in the tank, or another fish). Data are mean Ϯ SEM. Bars with dissimilar superscripts indicate groups that differ significantly (a, b, and c for food intake; a and b for FA; aЈand bЈ for TA).
has never been detected in the gastrointestinal tract (2, 11) , suggesting that CART peptides are synthesized in other tissues and transported to the gut, perhaps via sensory fibers or the vagus nerve. Indeed, CART immunoreactivity is found in vagal efferent fibers, often colocalized with cholecystokinin receptors, suggesting that CART peptides may mediate cholecystokinin satiety effects (54) .
CART mRNA was detected in the kidney, gills, and gonads of goldfish. To our knowledge, this is the first report of the presence of CART peptides in peripheral tissues of fish. In rats, CART immunoreactivity or mRNA is not present in the kidneys or respiratory tract (2, 11) but has been reported in the adrenal medulla. Because in teleost fish, the adrenal medulla intermingles with the interrenal tissue, the presence of CART mRNA in goldfish kidney might be a consequence of a contamination with adrenal tissue.
CART immunoreactive fibers have been reported in the vas deferens and epididymis of male rats (55). However, Douglass et al. (2) failed to detect CART mRNA in either testis or ovaries. It is possible that CART mRNA was not detected in gonads owing to the poor sensitivity of the method used (i.e. Northern blot). CART peptides appear to have some role in reproduction because differences in expression of CART have been reported in rat amygdala (56) and CART might influence the pituitary-gonadal axis (57, 58) . The significance of the presence of CART and its biological function in goldfish gonads requires further investigation.
Influence of nutritional status and leptin injection on CART mRNA expression
Postprandial variations of CART I mRNA expression were seen in goldfish hypothalamus and olfactory bulbs, whereas CART II expression showed no postprandial variations. Levels of CART I mRNA increased 2 h following a meal and returned to basal levels (levels at meal time) after 6 h. Similar variations in mRNA expression have been reported in goldfish for orexigenic peptides, such NPY (59, 60) and anorexigenic peptides such as tachykinin (49) and cholecystokinin (48) mRNAs. The existence of a feeding-related pattern in CART I expression further indicates a role of this peptide in regulation of food intake in goldfish.
Fasting induced significant reduction in levels of CART I mRNA.
These results are consistent with what is known in mammals. Hypothalamic levels of CART mRNA are decreased in hypoleptimic states, such as seen in obese ob/ob or anorexic anx/anx mice, and after prolonged fasting (16, (33) (34) (35) . CART II expression was little affected by fasting. A small but significant decrease was observed only in the olfactory bulbs. Taken together with the lack of postprandial variations in CART II mRNA expression, our results indicate that CART II is not involved in the regulation of feeding in goldfish. It is possible, however, that a more sensitive method than slot blot analysis might be needed to detect small variations in CART II expression associated with feeding behavior. It is also possible that more pronounced changes in nutritional status (e.g. a food deprivation of several weeks) may be necessary to trigger detectable variations in CART II expression.
Our results demonstrate that leptin at low ICV doses, that do not significantly affect feeding when given alone, enhance the inhibitory effects of CART peptide on feeding behavior of goldfish. In mammals (35, 61) and reptiles (62) , peripheral and central administration of leptin induces a significant decrease in food intake. In fish, data on leptin remain contradictory. Indirect evidence points to the presence of a leptin-like molecule in fish. Immunoreactivity to an antibody against mammalian leptin was demonstrated in eel (63) , six species of bony fish (64) , and lamprey (65) . Furthermore, the amount of leptin-like immunoreactivity appears to increase in fasted fish and be correlated with percentage of body fat (64) . However, Baker et al. (66) failed to show any effect of ip injection of human leptin in immature coho salmon; following 2-4 wk of continuous injection of leptin via implanted osmotic pumps, fish showed no variations in growth, body weight, or energy storage. Our results show that, although leptin alone at low doses has no effects on food intake of goldfish, it regulates the action of at least one appetiteregulating peptide (i.e. CART). These are not only short-term effects, as seen in the rapid effects in feeding behavior (30 min), but also long-term effects because leptin influences CART mRNA expression in the brain. This is the first report of a functional action of a leptin-like molecule in fish. The apparent discrepancy between our results and the findings of Baker et al. (66) might be simply owing to the difference in the animal used (immature salmon vs. mature goldfish) and in the methodology (peripheral vs. central administration, long-term vs. short-term effects, measure of food intake vs. measure of body weight). In rodents, peripheral administration of recombinant leptin has been shown to increase CART mRNA levels in the arcuate nucleus (16, 18) and to induce Fos expression in hypothalamic CART neurons. In situ hybridization histochemistry studies show that hypothalamic CART neurons express leptin-receptor mRNA, indicating that leptin directly acts on CART neurons in distinct nuclei of the rat hypothalamus (18, 60) . It is noteworthy that CART appears to be a mediator of the effects of leptin not only in the control of appetite but also in the hypothalamic control of the pituitary-gonadal axis (57, 58) . Such a role of CART peptides in the reproductive function of goldfish has yet to be investigated.
Conclusion
The present study identifies the cDNA and deduced amino acid sequences of two CART peptides in goldfish brain. The two forms of CART isolated in this study show a high degree of homology with mammalian CART. The two forms have distinct brain distributions and gene expression of one of the forms responds to feeding and fasting. This indicates that at least one of the CART forms is involved in the regulation of feeding behavior in the goldfish. There is a widespread localization of the two goldfish CART mRNAs in pituitary and various brain regions. The demonstration that fasting, nutritional status, and leptin treatment alter CART brain mRNA expression is a further indication that these peptides are involved in the regulation of feeding in goldfish. The high evolutionary conservation of CART peptides indicates an important role in the physiology of vertebrates. 
